|
Market Cap (17-May) $7,515,405 (818th) |
Close (30-Jun) $0.004 |
Volume (30-Jun) 780,000 |
Shortsold (11-Feb) 8,518 (0.01%) (552nd) |
|
52w High $0.60 |
52w Low $0.095 |
P/E - |
EPS -0.11 |
IVX released this announcement to the ASX on 21 September 2022, 8:56. The announcement is not marked as price sensitive, and is 12 page(s) in length and 36.75kb in size.
You can view all announcements from IVX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IVX was 0.001% short sold according to ASIC data. It was ranked the 660th most shorted stock on the ASX. It is now ranked as the 552nd most shorted stock on the ASX with 0.012% of total shares short sold as of the latest reported data (11 February 2025).
| Other Recent Announcements from IVX | |
|---|---|
| Notification regarding unquoted securities - IVX | 11 May 2023, 8:38 |
| Change of Director's Interest Notice- Robert Merriel | 2 May 2023, 16:45 |
| Section 708A Cleansing Statement | 2 May 2023, 16:42 |
| Application for quotation of securities - IVX | 21 September 2022, 8:56 |
| INV043 Effective Against Anal Cancer SCC In Vitro | 15 September 2022, 9:04 |
| Change of Director's Interest Notice - Alistair Bennallack | 13 September 2022, 15:43 |
| Change of Director's Interest Notice- Alan Yamashita | 13 September 2022, 15:41 |
You must be logged in to post a reply.
Invion 